Controlled substance prescribing trends and physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription Monitoring Program from 2006 to 2010

References

• Agresti, A. (2002). Categorical data analysis. Hoboken, NJ: John Wiley & Sons, Inc.
   Google Scholar
• Agresti, A., Bini, M., Bertaccini, B., & Ryu, E. (2008). Simultaneous confidence intervals for comparing binomial parameters. Biometrics, 64(4), 1270–1275.
   PubMedGoogle Scholar
• Buurma, H., Bouvy, M. L., De Smet, P. A., Floor-Schreudering, A., Leufkens, H. G., & Egberts, A. C. (2008). Prevalence and determinants of pharmacy shopping behaviour. Journal of Clinical Pharmacy and Therapeutics, 33, 17–23.
   PubMed Web of Science ®Google Scholar
• Dahl, J. L., & Gordon, D. B. (2002). Joint Commission pain standards: A progress report. APS Bulletin, 12, 6.
   Google Scholar
• El-Aneed, A., Alagherbandan, R., Gladney, N., Collins, K., Macdonald, D., & Fischer, B. (2009). Prescription drug abuse and methods of diversion: The potential role of a pharmacy network. Journal of Substance Use, 14(2), 75–83.
   Web of Science ®Google Scholar
• Epidemic: Responding to America’s Prescription Drug Abuse Crisis. (2011). Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan.pdf
   Google Scholar
• Hall, A. J., Logan, J. E., Toblin, R. L., Kaplan, J. A., Kraner, J. C., Bixler, D., & Paulozzi, L. J. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613–2620.
   PubMed Web of Science ®Google Scholar
• Joranson, D. E., & Gilson, A. M. (2005). Drug crime is a source of abused pain medications in the United States. Journal of Pain and Symptom Management, 30, 299–301.
   PubMed Web of Science ®Google Scholar
• Katz, N., Panas, L., Kim, M., Audet, A. D., Bilansky, A., Eadie, J., & Carrow, G. (2010). Usefulness of prescription monitoring programs for surveillance: Analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006. Pharmacoepidemiol and Drug Safety, 19, 115–123.
   PubMed Web of Science ®Google Scholar
• Maine Office of Substance Abuse Community Epidemiology Surveillance Network. (2010). Substance abuse trends in maine. Retrieved from http://www.maine.gov/dhhs/osa/pubs/data/2010/CESN_Report_03_2010.pdf
   Google Scholar
• Maine Prescription Monitoring Program. (2010). Information for prescribers. Retrieved from http://maine.gov/dhhs/osa/data/pmp/prescriber.htm
   Google Scholar
• Paolozzi, L. J., Hones, C. M., Mack, K. A., & Rudd, R. A. (2011). Vital signs: Overdoses of prescription opioid pain relievers – United States, 1999–2008. MMWR, 60(43), 1487–1492.
   PubMedGoogle Scholar
• Pastor, P. N., & Reuben, C. A. (2008). Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006. National Center for Health Statistics. Vital and Health Statistics, 10(237), 1–22.
   Google Scholar
• Pradel, V., Frauger, E., Thirion, X., Ronfle, E., Lapierre, V., Masut, A., Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol and Drug Safety, 18, 36–43.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Retrieved from http://www.R-project.org/.
   Google Scholar
• SAS Institute Inc. (2008). Enhancements in SAS 9.2 Software. Cary, NC: SAS Institute Inc.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings). Retrieved from http://www.samhsa.gov/data/2k9/2k9Resultsweb/web/2k9results.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2010). Treatment Episode Data Set (TEDS): 1998–2008. State admissions to substance abuse treatment services, DASIS Series: S-55, HHS Publication No. (SMA) 10-4613. Retrieved from http://www.samhsa.gov/data/DASIS/TEDS2k8St_nov04.pdf
   Google Scholar
• US Census Bureau. United States Census (2010). Retrieved from http://2010.census.gov/2010census/index.php
   Google Scholar
• US Department of Health and Human Services, National Institutes of Health. National Institute on Drug Abuse Research Report Series: Prescription Drugs Abuse and Addiction. (2005). Retrieved from http://www.nida.nih.gov/ResearchReports/Prescription/Prescription.html
   Google Scholar
• US Department of Justice Drug Enforcement Administration Office of Diversion Control. (2011). Controlled substance schedules. Retrieved from http://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf
   Google Scholar
• Warner, M., Chen, L. H., & Makuc, D. M. (2009). Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief, Sep:(22):1–8. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db22.htm.
   Google Scholar
• White, A. G., Birnbaum, H. G., Schiller, M., Tang, J., & Katz, N. P. (2009). Analytic models to identify patients at risk for prescription opioid abuse. American Journal of Managed Care, 15(12), 897–906.
   PubMed Web of Science ®Google Scholar
• Wilsey, B. L., Fishman, S. M., Gilson, A. M., Casamalhuapa, C., Baxi, H., Lin, T. C., Li, CS. (2011). An analysis of the number of multiple prescribers for opioids utilizing data from the California prescription monitoring program. Pharmacoepidemiol and Drug Safety, 20(12), 1262–1268.
   PubMedGoogle Scholar